The value of transperineal pelvic floor ultrasound parameters in monitoring pelvic floor dysfunction diseases and in guiding pelvic floor rehabilitation treatment
Objective To explore the value of transperineal pelvic floor ultrasound parameters in monitoring pelvic floor dysfunction(PFD)diseases and in guiding pelvic floor rehabilitation treatment.Methods A total of 119 patients with PFD diagnosed at 42 d postpartum in Lianyungang Maternal and Child Health Hospital were selected as study subjects and divided into a primigravida group(n=59)and a multipara group(n=60)according to the status of delivery.The pelvic floor ultrasound parameters were compared between the two groups and between patients with different modes of delivery.All patients were treated with pelvic floor rehabilitation,and the efficacy was measured after 1 month of treatment to analyze the value of each parameter in predicting the efficacy.Results Urethral rotation angle,posterior bladder angle,bladder mobility,and anal raphe fissure area(maximal Valsalva action)were higher in the multipara group than in the primigravida group(P＜0.05);urethral rotation angle,posterior bladder angle,bladder mobility,and anal raphe fissure area(maximal Valsalva action)of pregnant women with natural delivery were higher than those with cesarean section in the two groups(P＜0.05).The pre-treatment urethral rotation angle,posterior bladder angle,bladder mobility,and anal raphe fissure area(maximal Valsalva action)were all higher in patients with poor efficacy than those with good efficacy in PFD patients(P＜0.05).The area under the curve(AUC)of pre-treatment urethral rotation angle,posterior bladder angle,bladder mobility,and anal raphe fissure area(maximal Valsalva action)predicting poor efficacy pelvic floor rehabilitation in PFD patients was 0.821,0.771,0.732,and 0.703,respectively.Conclusions Transperineal pelvic floor ultrasound parameters can monitor PFD condition,and provide reference for clinical prediction of the efficacy of pelvic floor rehabilitation and judging of disease outcome.
万方数据
维普
